End Stage Liver Disease: Clinical Trials

151 trials for End Stage Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

67 completed, 31 unknown, 21 recruiting, 13 terminated. 58 Not applicable, 16 Phase 1, 16 Phase 2, 8 Phase 3, 8 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable58Completed 29, Recruiting 9, Unknown 8, Terminated 4, Active not recruiting 3, Not yet recruiting 2, Withdrawn 2, Suspended 1
Phase 116Unknown 7, Completed 5, Recruiting 3, Active not recruiting 1
Phase 216Completed 7, Unknown 4, Recruiting 2, Terminated 2, Active not recruiting 1
Phase 38Completed 4, Unknown 2, Recruiting 1, Terminated 1
Phase 48Terminated 3, Completed 2, Unknown 2, Active not recruiting 1
Early Phase 13Completed 2, Withdrawn 1

Follow End Stage Liver Disease: new trials by email Literature Review of End Stage Liver Disease trials Research Report on End Stage Liver Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VitaSmart HOPE System: Bridge to HOPE Registry
hypothermic oxygenated perfusion therapy of a donor liver under standard of care conditions - End Stage Liver DIsease, Liver Failure
Enrolling by invitationBridge to Life Ltd.50002026-09-012026-05-22
Evaluating Novel Scoring Systems to Predict Outcomes in Acute-on-Chronic Liver Failure
Acute-on-Chronic Liver Failure (ACLF), Liver Cirrhosis
Not yet recruitingAssiut University1002026-08-012026-07-29
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
Preoperative Oral Carbohydrate Loading, Placebo - Liver Transplantation, Liver Transplant
Not applicableRecruitingMedical University of Warsaw4342026-05-272026-06-03
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Endischemic hypothermic oxygenated machine perfusion (any device), Endischemic (back-to-base) normothermic machine perfusion (any device), Continuous (device-to-donor) normothermic machine perfusion (any device) - End-stage Liver Disease (ESLD), Acute Liver Failure
RecruitingUniversity Medical Center Groningen100002026-04-212026-10-22
Immune Tolerance Induction After Liver Transplantation
Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles122026-02-202026-03-12
Restrictive Fluid Management In Liver Transplantation (REFIL)
Low splanchnic blood volume restrictive fluid management strategy, Phlebotomy, Optimized cardiac output liberal fluid management strategy - Liver Transplantation (LT), End-stage Liver Disease (ESLD)
Not applicableRecruitingCentre hospitalier de l'Université de Montréal (CHUM)8662026-02-152026-07-10
Nutrition and Exercise Prehabilitation in Patients Awaiting Liver Transplantation
Diet with even protein distribution plus exercise program, Diet with skewed protein distribution plus exercise program, Standard dietary and physical activity advice - End-stage Liver Disease, Liver Cirrhosis
Not applicableRecruitingKalliopi Anna Poulia902026-01-082026-05-01
Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Comprehensive Observational Assessment in Liver Transplant Candidates - End-Stage Liver Disease, Liver Transplantation
RecruitingIzmir Bakircay University602025-12-152026-02-17
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
tranexamic acid, 0.9 % saline - Liver Transplantation, Tranexamic Acid
Not applicableRecruitingRenJi Hospital15462025-11-012025-12-08
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Hepatology Home Hospital - Cirrhosis, End Stage Liver DIsease
Not applicableRecruitingMassachusetts General Hospital302025-07-212026-10-07
Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation
Transfusion algorithm based on Quantra®, Conventional transfusion algorithm - Liver Transplantation
Not applicableRecruitingUniversity Hospital, Toulouse562025-03-082025-09-22
View of Cerebral Perfusion in Liver Transplantation
Carotid Doppler Ultrasonography and Near-Infrared Spectroscopy (NIRS) - End-stage Liver Disease (ESLD), Liver Transplantation
Active not recruitingInonu University432025-02-012026-03-02
Physical and Cognitive Outcomes After Post-Transplant Physiotherapy in Liver Transplant Recipients
Routine Post-Transplant Physiotherapy - Liver Transplantation (LT), End-Stage Liver Disease
CompletedHasan Kalyoncu University1062024-10-272026-07-10
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
RTX001 - End-stage Liver Disease (ESLD), Cirrhosis, Liver
Phase 1 / Phase 2Active not recruitingResolution Therapeutics Limited302024-10-152026-10-05
Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients
Aerobic and resistance exercise, Respiratory physiotherapy - Liver Transplant Disorder, Liver Transplant; Complications
Not applicableUnknownTehran University of Medical Sciences402024-10-012024-09-27
A Study of SIPLIZUMAB in AILD and LT Patients
Siplizumab - Autoimmune Liver Disease, Liver Transplant Disorder
Phase 1RecruitingElizabeth C. Verna82024-09-112025-11-24
Surprise Question in End of Life (SeQuEL) Care and the Effect of Prompting Palliative Care Consultation: End-Stage Liver Disease
Prompted Palliative Care Consult - End-Stage Liver Disease
Not applicableCompletedVanderbilt University Medical Center972024-08-052025-08-19
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
LiverWatch Intervention - Cirrhosis, Liver, End Stage Liver DIsease
Not applicableActive not recruitingUniversity of Pennsylvania1102024-05-012026-08-10
Effect of Different Frequencies of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
umbilical cord-mesenchymal stem cells - End-Stage Liver DIsease
Not applicableCompletedGeneral Hospital of Shenyang Military Region922024-03-052026-03-31
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
a single course of micro-encapsulated hepatocytes intraperitoneal transplantation therapy - Acute-On-Chronic Liver Failure, Chronic Liver Failure
Phase 1RecruitingRenJi Hospital102024-03-012025-06-27

Showing 20 of 151. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (26)  ·  Fibrosis (24)  ·  Liver Diseases (15)  ·  Sarcopenia (11)  ·  Kidney Failure, Chronic (9)  ·  Frailty (8)  ·  Liver Failure (8)  ·  Hepatic Encephalopathy (7)  ·  Hepatitis C (7)  ·  Hypertension, Portal (7)  ·  Liver Failure, Acute (7)  ·  Heart Failure (6)  ·  Acute Kidney Injury (5)  ·  Acute-On-Chronic Liver Failure (5)

Broader conditions

Hepatic Insufficiency (151)  ·  Digestive System Diseases (150)  ·  Liver Failure (143)  ·  Liver Diseases (136)  ·  Pathological Conditions, Signs and Symptoms (73)  ·  Pathologic Processes (67)  ·  Nervous System Diseases (24)  ·  Fibrosis (21)  ·  Signs and Symptoms (21)  ·  Nutritional and Metabolic Diseases (19)  ·  Female Urogenital Diseases (18)  ·  Female Urogenital Diseases and Pregnancy Complications (18)  ·  Kidney Diseases (18)  ·  Male Urogenital Diseases (18)  ·  Urogenital Diseases (18)

Interventions

Mycophenolic Acid (4)  ·  Liver Transplantation (3)  ·  Anti-Bacterial Agents (2)  ·  Glutathione (2)  ·  Mass Screening (2)  ·  Observation (2)  ·  Phlebotomy (2)  ·  Resistance Training (2)  ·  Thrombelastography (2)  ·  Tocotrienols (2)  ·  Analgesia, Patient-Controlled (1)  ·  Angiotensin II (1)  ·  Basiliximab (1)  ·  Blood Specimen Collection (1)  ·  Bretschneider cardioplegic solution (1)

Sponsors

Mayo Clinic (5)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (4)  ·  Massachusetts General Hospital (4)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (4)  ·  RenJi Hospital (4)  ·  Air Force Military Medical University, China (3)  ·  Baylor Research Institute (3)  ·  Tongji Hospital (3)  ·  University of California, Los Angeles (3)  ·  University of California, San Francisco (3)  ·  University of Pennsylvania (3)  ·  University of Washington (3)  ·  Albert Einstein Healthcare Network (2)  ·  Arbor Research Collaborative for Health (2)  ·  Asan Medical Center (2)

Countries

United States (65)  ·  China (14)  ·  Canada (12)  ·  United Kingdom (9)  ·  India (7)  ·  Italy (7)  ·  Spain (7)  ·  Belgium (6)  ·  France (6)  ·  South Korea (6)  ·  Turkey (Türkiye) (6)  ·  Netherlands (5)  ·  Austria (4)  ·  Switzerland (4)  ·  Brazil (3)

Top investigators

Daiming Fan (3)  ·  J. Randall Curtis, MD, MPH (2)  ·  James Trotter, MD (2)  ·  Jennifer C Lai, MD, MBA (2)  ·  Kymberly Watt, MD (2)  ·  Victor Navarro, MD (2)  ·  Won Ho Kim, MD, PhD (2)  ·  Achal Dhir, MD (1)  ·  Achuthan Sourianarayanane (1)  ·  Adrian H Cotterell, MD, FACS (1)  ·  Alfonso W Avolio (1)  ·  Amrish Sahney, MD (1)  ·  Amy E Taylor, MD (1)  ·  Anders Boyd, MPH, PhD (1)

Results publications

PMID 10189326, PMID 10218526, PMID 10371175, PMID 10546860, PMID 10563713, PMID 10634199, PMID 10670636, PMID 10789605, PMID 10971863, PMID 10988097, PMID 11071184, PMID 11188837, PMID 11216928, PMID 11262215, PMID 11303131, PMID 11366976, PMID 11399982, PMID 11544428, PMID 11719381, PMID 11722270, PMID 11737323, PMID 11740189, PMID 11807691, PMID 11895160, PMID 12008784, PMID 12126821, PMID 12134254, PMID 12172088, PMID 12186514, PMID 12534953, PMID 12553482, PMID 12558340, PMID 12640206, PMID 12741625, PMID 12819520, PMID 12853195, PMID 12859325, PMID 12891060, PMID 12957089, PMID 14518432, PMID 14581998, PMID 14627784, PMID 14991809, PMID 14999610, PMID 1506645, PMID 15195254, PMID 15197808, PMID 15232720, PMID 15234856, PMID 15272393

NIH funding

2016 (1), 2017 (1), 2023 (1), R01NR009987 (1), R21AG067554 (1), R21DK127275 (1), U01DK062436 (1), U01DK062444 (1), U01DK062445 (1), U01DK062452 (1), U01DK062453 (1), U01DK062456 (1), U01DK062466 (1), U01DK062467 (1), U01DK062470 (1)